JP2019510060A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2019510060A5 JP2019510060A5 JP2018551299A JP2018551299A JP2019510060A5 JP 2019510060 A5 JP2019510060 A5 JP 2019510060A5 JP 2018551299 A JP2018551299 A JP 2018551299A JP 2018551299 A JP2018551299 A JP 2018551299A JP 2019510060 A5 JP2019510060 A5 JP 2019510060A5
- Authority
- JP
- Japan
- Prior art keywords
- composition
- plant material
- thc
- cannabis
- cbd
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 239000000203 mixture Substances 0.000 claims 19
- 241000218236 Cannabis Species 0.000 claims 14
- 239000000463 material Substances 0.000 claims 14
- CYQFCXCEBYINGO-UHFFFAOYSA-N THC Natural products C1=C(C)CCC2C(C)(C)OC3=CC(CCCCC)=CC(O)=C3C21 CYQFCXCEBYINGO-UHFFFAOYSA-N 0.000 claims 11
- ZTGXAWYVTLUPDT-UHFFFAOYSA-N cannabidiol Natural products OC1=CC(CCCCC)=CC(O)=C1C1C(C(C)=C)CC=C(C)C1 ZTGXAWYVTLUPDT-UHFFFAOYSA-N 0.000 claims 11
- CYQFCXCEBYINGO-IAGOWNOFSA-N delta1-THC Chemical compound C1=C(C)CC[C@H]2C(C)(C)OC3=CC(CCCCC)=CC(O)=C3[C@@H]21 CYQFCXCEBYINGO-IAGOWNOFSA-N 0.000 claims 11
- 229960004242 dronabinol Drugs 0.000 claims 11
- QHMBSVQNZZTUGM-UHFFFAOYSA-N Trans-Cannabidiol Natural products OC1=CC(CCCCC)=CC(O)=C1C1C(C(C)=C)CCC(C)=C1 QHMBSVQNZZTUGM-UHFFFAOYSA-N 0.000 claims 10
- QHMBSVQNZZTUGM-ZWKOTPCHSA-N cannabidiol Chemical compound OC1=CC(CCCCC)=CC(O)=C1[C@H]1[C@H](C(C)=C)CCC(C)=C1 QHMBSVQNZZTUGM-ZWKOTPCHSA-N 0.000 claims 10
- 229950011318 cannabidiol Drugs 0.000 claims 10
- PCXRACLQFPRCBB-ZWKOTPCHSA-N dihydrocannabidiol Natural products OC1=CC(CCCCC)=CC(O)=C1[C@H]1[C@H](C(C)C)CCC(C)=C1 PCXRACLQFPRCBB-ZWKOTPCHSA-N 0.000 claims 10
- 241000196324 Embryophyta Species 0.000 claims 6
- 208000022559 Inflammatory bowel disease Diseases 0.000 claims 5
- 208000011231 Crohn disease Diseases 0.000 claims 4
- 208000024891 symptom Diseases 0.000 claims 4
- VBGLYOIFKLUMQG-UHFFFAOYSA-N Cannabinol Chemical compound C1=C(C)C=C2C3=C(O)C=C(CCCCC)C=C3OC(C)(C)C2=C1 VBGLYOIFKLUMQG-UHFFFAOYSA-N 0.000 claims 2
- 230000000391 smoking effect Effects 0.000 claims 2
- 230000008016 vaporization Effects 0.000 claims 2
- 238000009834 vaporization Methods 0.000 claims 2
- 235000004936 Bromus mango Nutrition 0.000 claims 1
- 208000014997 Crohn colitis Diseases 0.000 claims 1
- 240000007228 Mangifera indica Species 0.000 claims 1
- 235000014826 Mangifera indica Nutrition 0.000 claims 1
- 235000009184 Spondias indica Nutrition 0.000 claims 1
- 239000008280 blood Substances 0.000 claims 1
- 210000004369 blood Anatomy 0.000 claims 1
- 229930003827 cannabinoid Natural products 0.000 claims 1
- 239000003557 cannabinoid Substances 0.000 claims 1
- 229960003453 cannabinol Drugs 0.000 claims 1
- 206010009887 colitis Diseases 0.000 claims 1
- 230000009266 disease activity Effects 0.000 claims 1
- 239000002552 dosage form Substances 0.000 claims 1
- 229940079593 drug Drugs 0.000 claims 1
- 239000003814 drug Substances 0.000 claims 1
- 230000002550 fecal effect Effects 0.000 claims 1
- 230000002757 inflammatory effect Effects 0.000 claims 1
- 150000003505 terpenes Chemical class 0.000 claims 1
- 235000007586 terpenes Nutrition 0.000 claims 1
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201662313882P | 2016-03-28 | 2016-03-28 | |
| US62/313,882 | 2016-03-28 | ||
| PCT/IL2017/050388 WO2017168422A1 (en) | 2016-03-28 | 2017-03-28 | Cannabionid and cannabis-based compositions and methods for the treatment of inflammatory conditions of the gastrointestinal tract |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2019510060A JP2019510060A (ja) | 2019-04-11 |
| JP2019510060A5 true JP2019510060A5 (cg-RX-API-DMAC7.html) | 2020-05-07 |
Family
ID=58579244
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2018551299A Pending JP2019510060A (ja) | 2016-03-28 | 2017-03-28 | 胃腸管の炎症性疾患の治療のためのカンナビノイドおよびカンナビスベースの組成物および方法 |
Country Status (11)
| Country | Link |
|---|---|
| US (2) | US20190091198A1 (cg-RX-API-DMAC7.html) |
| EP (1) | EP3436001A1 (cg-RX-API-DMAC7.html) |
| JP (1) | JP2019510060A (cg-RX-API-DMAC7.html) |
| KR (1) | KR20180130544A (cg-RX-API-DMAC7.html) |
| AU (1) | AU2017242161A1 (cg-RX-API-DMAC7.html) |
| BR (1) | BR112018069860A2 (cg-RX-API-DMAC7.html) |
| CA (1) | CA3018951A1 (cg-RX-API-DMAC7.html) |
| IL (1) | IL261799A (cg-RX-API-DMAC7.html) |
| MX (1) | MX2018011392A (cg-RX-API-DMAC7.html) |
| WO (1) | WO2017168422A1 (cg-RX-API-DMAC7.html) |
| ZA (1) | ZA201807098B (cg-RX-API-DMAC7.html) |
Families Citing this family (16)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2019130215A1 (en) * | 2017-12-27 | 2019-07-04 | To Pharmaceuticals Llc | Cannabis compositions for the treatment of inflammatory skin disorders |
| MX2020007394A (es) | 2018-01-10 | 2020-09-03 | Brightseed Inc | Metodo para modular el metabolismo. |
| WO2019159185A1 (en) * | 2018-02-19 | 2019-08-22 | To Pharmaceuticals Llc | Compositions and methods for the treatment of protein energy wasting |
| US20210393572A1 (en) * | 2018-09-28 | 2021-12-23 | Visceral Therapeutics Inc. | Pharmaceutically active cannabis-based compositions and methods of use for treating gastrointestinal conditions |
| CA3122691A1 (en) * | 2018-12-10 | 2020-06-18 | Natural Extraction Systems, LLC | Compositions with novel cannabinoid and terpene profiles |
| AU2019412825A1 (en) * | 2018-12-27 | 2021-08-12 | Buzzelet Development And Technologies Ltd. | Herbal preparation-enriched cannabinoid composition and method of treatment |
| US10993928B2 (en) | 2019-04-26 | 2021-05-04 | Natural Extraction Systems, LLC | Compositions comprising non-crystalline forms of cannabidiol |
| CA3137559A1 (en) * | 2019-04-26 | 2020-10-29 | Natural Extraction Systems, LLC | Compositions comprising non-crystalline forms of cannabidiol |
| WO2021021744A1 (en) * | 2019-07-29 | 2021-02-04 | Lee Chae | Method for improving digestive health |
| WO2021113261A1 (en) * | 2019-12-02 | 2021-06-10 | Natural Extraction Systems, LLC | Compositions comprising novel cannabinoid and terpene profiles |
| AU2021206021A1 (en) * | 2020-01-08 | 2022-06-02 | Société des Produits Nestlé S.A. | Oral solid cannabinoid oil composition for treating gastrointestinal disorders |
| MX2022015799A (es) * | 2020-06-12 | 2023-04-11 | Zelira Therapeutics Operations Pty Ltd | Composicion y metodo para el tratamiento del dolor cronico. |
| GB202101732D0 (en) * | 2021-02-08 | 2021-03-24 | Tts Pharma Ltd | A cannabinoid mixture |
| CA3227884A1 (en) | 2021-08-04 | 2023-02-09 | John Crawford | Cannabinoid derivatives and their use |
| WO2023060323A1 (en) * | 2021-10-15 | 2023-04-20 | Bod Science Limited | Terpene-containing formulations and use thereof |
| US11977085B1 (en) | 2023-09-05 | 2024-05-07 | Elan Ehrlich | Date rape drug detection device and method of using same |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB2450741A (en) * | 2007-07-05 | 2009-01-07 | Gw Pharma Ltd | Cannabinoid containing plant extracts in the treatment of inflammatory bowel disease |
| US20140245495A1 (en) | 2013-02-25 | 2014-08-28 | Ytzchak Cohen | Cannabis plant named midnight |
| US20140245494A1 (en) | 2013-02-25 | 2014-08-28 | Ytzchak Cohen | Cannabis plant named erez |
| US20140259228A1 (en) | 2013-02-25 | 2014-09-11 | Ytzchak Cohen | Cannabis plant named 'avidekel' |
-
2017
- 2017-03-28 AU AU2017242161A patent/AU2017242161A1/en not_active Abandoned
- 2017-03-28 KR KR1020187031360A patent/KR20180130544A/ko not_active Ceased
- 2017-03-28 EP EP17718623.6A patent/EP3436001A1/en not_active Withdrawn
- 2017-03-28 JP JP2018551299A patent/JP2019510060A/ja active Pending
- 2017-03-28 CA CA3018951A patent/CA3018951A1/en not_active Abandoned
- 2017-03-28 WO PCT/IL2017/050388 patent/WO2017168422A1/en not_active Ceased
- 2017-03-28 BR BR112018069860-1A patent/BR112018069860A2/pt not_active Application Discontinuation
- 2017-03-28 US US16/086,338 patent/US20190091198A1/en not_active Abandoned
- 2017-03-28 MX MX2018011392A patent/MX2018011392A/es unknown
-
2018
- 2018-09-16 IL IL261799A patent/IL261799A/en unknown
- 2018-10-24 ZA ZA2018/07098A patent/ZA201807098B/en unknown
-
2020
- 2020-01-28 US US16/774,270 patent/US20200397743A1/en not_active Abandoned
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2019510060A5 (cg-RX-API-DMAC7.html) | ||
| Gautam et al. | Immunity against COVID-19: potential role of Ayush Kwath | |
| Byeon et al. | In vitro and in vivo anti-inflammatory effects of taheebo, a water extract from the inner bark of Tabebuia avellanedae | |
| JP2020524151A5 (cg-RX-API-DMAC7.html) | ||
| JP2012532093A5 (cg-RX-API-DMAC7.html) | ||
| JP2018530517A5 (cg-RX-API-DMAC7.html) | ||
| JP2016523862A5 (cg-RX-API-DMAC7.html) | ||
| KR20130131303A (ko) | 항피로 조성물, 그의 제형 및 용도 | |
| JP2022105649A5 (cg-RX-API-DMAC7.html) | ||
| JP2011513340A5 (cg-RX-API-DMAC7.html) | ||
| CN107007696A (zh) | 一种中药复方灌肠制剂及其制备和使用方法 | |
| Bhattacharjee et al. | Role of turmeric in management of different non-communicable diseases | |
| JP2014533256A5 (cg-RX-API-DMAC7.html) | ||
| CN104000814B (zh) | 一种防治痛风性关节炎的药物组合物及其用途 | |
| US20090191293A1 (en) | Composition for enhancing immunity and reducing inflammation related to infections | |
| JP2023527409A (ja) | Ｃｏｖｉｄ－１９および関連する疾患の管理のための組成物 | |
| WO2018167635A1 (en) | Composition for use in the treatment of endometriosis and symptoms associated with endometriosis | |
| Mohammed et al. | Drug repositioning for the prophylaxis and treatment of COVID-19 | |
| JP2017511307A5 (cg-RX-API-DMAC7.html) | ||
| JP2016040314A5 (ja) | 血圧降下作用及び心拍数低下作用を有する組成物および機能性食品、並びにヤナギタデ抽出物の製造方法 | |
| CN104095868B (zh) | 一种提高糖耐量的药物组合物及其制药用途 | |
| IT201800006474A1 (it) | Composizione per l’uso nella prevenzione e/o nel trattamento di patologie osteoarticolari. | |
| CN102114104A (zh) | 白鲜皮提取物抗动脉粥样硬化的新用途 | |
| Mittal et al. | Role of Medicinal Plants in Treatment of Pulmonary Edema | |
| Al-Noaemi Mohammed et al. | Drug Repositioning For The Prophylaxis And Treatment of COVID-19 |